Top Markets
#1 Seeker Seeker +129.13%
#2 MowCat MowCat +107.71%
#3 AI XOVIA AI XOVIA +105.43%
#4 Helium Helium +86.38%
#5 Pons Pons +55.10%
#6 UnifAI Network UnifAI Network +34.96%
#7 Zora Zora +31.04%
#8 Bounce Bounce +21.20%
#9 Zylo Ecosystem Zylo Ecosystem +21.16%
#10 Tensor Tensor +18.98%
Coin of the day
Seeker Seeker
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Jacobio Pharmaceuticals Group Co., Ltd. Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.

1167
Pozycja w akcjach #11796
Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage pharmaceutical firm... Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage pharmaceutical firm specializing in the proprietary discovery and development of oncology therapies. Its primary drug development initiatives feature two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors, JAB-3312 and JAB-3068, which are being investigated for esophageal cancer. Also in development is JAB-8263, a small molecule designed to inhibit BET family proteins that regulate MYC transcription, aiming to treat a range of cancers, alongside JAB-21822, an oral small molecule specifically targeting the mutant KRAS G12C protein. Jacobio is further advancing JAB-BX102, a humanized inhibitory antibody against human CD73, intended for treating PD-1 resistant cancers. Other pipeline assets include JAB-6343, an inhibitor targeting fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma exhibiting FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor for solid tumors; JAB-24114, which targets a tumor metabolic pathway for solid tumor treatment; and JAB-BX300, a molecular antibody designed to target the RAS pathway for pancreatic and other solid tumors with KRAS mutations. The company maintains a strategic partnership with AbbVie Ireland Unlimited Company for the development and commercialization of SHP2 inhibitors. Established in 2015, Jacobio Pharmaceuticals is headquartered in Beijing, China.
Cena akcji
$0.84111496
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$657.90M
Zmiana (1 dzień)
-0.75%
Zmiana (1 rok)
-19.13%
Kraj
CN
Handel Jacobio Pharmaceuticals Group Co., Ltd. (1167)

Kategoria

Healthcare
Historia ceny akcji dla Jacobio Pharmaceuticals Group Co., Ltd. (1167)
Najwyższa cena zamknięcia: $0.70 dnia 2026-08-01

Najniższa cena zamknięcia: $1.84 dnia 2020-12-01
Historia cen akcji firmy Jacobio Pharmaceuticals Group Co., Ltd. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -15.43%
2025 484.68%
2024 -61.65%
2023 -33.34%
2022 -61.78%
2021 -1.98%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH